CNGC11 antibodies target the cyclic nucleotide-gated ion channel subunit alpha 11, a non-selective cation channel involved in calcium (Ca²⁺) transport and pathogen defense signaling . These antibodies are typically monoclonal or polyclonal reagents validated for techniques such as:
Key epitopes for CNGC11 antibodies often reside in cytoplasmic domains, such as the cyclic nucleotide-binding domain (CNBD) or C-terminal regulatory regions .
CNGC11 antibodies have been instrumental in characterizing autoimmune phenotypes in Arabidopsis mutants. Studies show:
Constitutive defense activation: Mutants like cpr22 (a CNGC11/12 chimera) exhibit spontaneous cell death and elevated salicylic acid levels, detectable via antibody-based protein analysis .
Calcium signaling: CNGC11 mediates Ca²⁺ influx during pathogen responses, as confirmed by electrophysiological assays using antibodies for protein localization .
Specificity: Anti-His tag antibodies are frequently used for recombinant CNGC11 detection, but custom antibodies targeting unique epitopes improve specificity .
Cross-reactivity: Some CNGC antibodies (e.g., NeuroMab L36/12) detect multiple subunits (CNGA1/CNGA3), necessitating validation for CNGC11 exclusivity .
Functional assays: Combining antibody-based detection with electrophysiology (e.g., patch-clamp) resolves channel activity dynamics .
Ongoing research aims to:
CNGC11 and CNGC12: Function and Interactions